secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001193125-23-009500
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum announces $100M stock offering and preliminary $202.9M cash position
----------------------------------------------------------------------------

- Preliminary cash, cash equivalents, and marketable securities of ~$202.9M as of Dec 31, 2022.
- Commenced underwritten public offering of $100M common stock, with 30-day option for additional $15M.
- Terminated ATM equity distribution agreement with Piper Sandler effective Jan 17, 2023.
- Goldman Sachs, SVB Securities, Piper Sandler joint book-runners; H.C. Wainwright lead manager.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312523009500/0001193125-23-009500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312523009500/d436290d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-009500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer